Ochratoxin A (OTA) is a carcinogen targeting proximal tubules at the renal outer medulla (ROM) in rodents. We previously reported that OTA increased mutant frequencies of the red/gam gene (Spi − ), primarily deletion mutations. In the present study, Spi − assays and mutation spectrum analyses in the Spi − mutants were performed using additional samples collected in our previous study. Spi − assay results were similar to those in our previous study, revealing large (>1 kb) deletion mutations in the red/gam gene. To clarify the molecular progression from DNA damage to gene mutations, in vivo comet assays and analysis of DNA damage/ repair-related mRNA and/or protein expression was performed using the ROM of gpt delta rats treated with OTA at 70, 210 or 630 µg/kg/day by gavage for 4 weeks. Western blotting and immunohistochemical staining demonstrated that OTA increased γ-H2AX expression specifically at the carcinogenic target site. In view of the results of comet assays, we suspected that OTA was capable of inducing double-strand breaks (DSBs) at the target sites. mRNA and/ or protein expression levels of homologous recombination (HR) repair-related genes (Rad51, Rad18 and Brip1), but not nonhomologous end joining-related genes, were increased in response to OTA in a dose-dependent manner. Moreover, dramatic increases in the expression of genes involved in G 2 /M arrest (Chek1 and Wee1) and S/G 2 phase (Ccna2 and Cdk1) were observed, suggesting that DSBs induced by OTA were repaired predominantly by HR repair, possibly due to OTA-specific cell cycle regulation, consequently producing large deletion mutations at the carcinogenic target site.
Introduction
Ochratoxin A (OTA), a nephrotoxic mycotoxin produced by several fungal species, is often found as a contaminant in agricultural products (1) . Since humans are exposed to OTA via consumption of various foods, the fact that OTA induces renal cell tumours with a high incidence in rodents suggests a possible cancer risk in humans (2-4). However, the mechanism through which OTA exerts its carcinogenic action is still controversial, particularly because genotoxicity tests have yielded both positive and negative results (5) . Recently, we showed that OTA increases mutant frequencies (MFs) of the red/gam gene (Spi − ) at the renal outer medulla (ROM), the carcinogenic target site of gpt delta rats (6) , suggesting involvement of genotoxic mechanisms in OTA-induced renal carcinogenesis.
The phenotype of the Spi − (sensitive to PII interference) mutation in gpt delta rodents represents inactivation of the functions of both the red and gam genes. Research has suggested that disruption of these genes in the Spi − mutant is caused by 1-10 000 bp deletions spanning these two tandem genes (7). 2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) and aminophenylnorharman are known to form specific DNA adducts on guanine base to induce single base pair deletions of G:C in the gam gene, possibly due to translesion synthesis of DNA adducts (8, 9) . Ionising radiation (IR), ultraviolet B (UVB) or mitomycin C (MMC), which are known to induce DNA double-strand breaks (DSBs), cause large deletions exceeding 1 kb at this locus including the red/gam genes, possibly through the DSB repair process (10) (11) (12) . Thus, mutagens elicit deletions of specific sizes and sequences in the red/gam genes and deletion mutation spectra analyses are informative in the determination of their induction mechanisms (7) . In the case of OTA, although mRNA levels of several genes related to DSB repair were changed at the carcinogenic target site by OTA treatment (13) , the detail mechanisms underlying OTAinduced mutagenesis remain unclear.
DSB repair is initiated by ataxia telangiectasia mutated (ATM)-mediated phosphorylation of histone variant H2AX (γ-H2AX), which subsequently recruits specific proteins corresponding to two major DSB repair systems, homologous recombination (HR) repair and nonhomologous end joining (NHEJ) (14) (15) (16) . Errors in the repair processes of the HR or NHEJ systems cause various mutations, including large deletions (7, 17, 18) . Accordingly, information on the fluctuations in gene and/or protein expression associated with DSB repair, in addition to changes in direct markers of DNA damage, could be helpful to understanding the mechanisms through which OTA induces mutagenesis.
In the present study, we performed Spi − assays and mutation spectrum analyses of Spi − mutants obtained from the ROM of gpt delta rats fed OTA at a carcinogenic dose for 4 weeks, as reported in our previous study (6) . Additionally, to clarify pathways leading from DNA damage to mutagenesis following OTA exposure, we performed in vivo comet assays and measured the expression levels of genes and proteins related to DNA damage/repair using the ROM of gpt delta rats treated with three different doses of OTA for 4 weeks.
Materials and methods

Experimental animals and housing conditions
The protocol for this study was approved by the Animal Care and Utilization Committee of the National Institute of Health Sciences. Specific pathogen-free, 5-week-old male F344/NSlc-Tg (gpt delta) rats carrying about five tandem copies of the transgene lambda EG10 per haploid genome were obtained from Japan SLC (Shizuoka, Japan) and acclimated for 1 week prior to the commencement of testing. Animals were housed in a room with a barrier system and maintained under a constant temperature (23 ± 2°C) and relative humidity (55 ± 5%). The air was changed 12 times/hr, and lighting was on a 12-h lightdark cycle. Animals had free access to tap water.
Test compound
OTA was extracted from a culture of Aspergillus ochraceus (BD-5). Fermentative production of OTA was performed based on the culture and extraction methods of Kumata et al. (19) , with minor modifications. Several 500-ml Erlenmeyer flasks containing 100 g of polished rice were autoclaved before the addition of 20 ml of sterilised water. The rice was inoculated with spores of A.ochraceus and incubated for 2 weeks at 25°C. After incubation, 200 ml of chloroform:acetic acid (99:1) was added to the moldy rice in each flask. The extracts collected from the flasks were concentrated and precipitated with 4 l of hexane on a stirrer. The precipitate was dissolved in 500 ml of chloroform and subjected to chromatography using a silica gel column and mobile phases of benzene:acetic acid (100:0 to 88:12) with a linear gradient. The benzene:acetic acid (95:5 and 92.5:7.5) eluates were evaporated to dryness. Benzene was added to the extract, and the solution was heated followed by gentle cooling for crystallisation of OTA. The purification of crystals was confirmed by high-performance liquid chromatography according to the method of Sugita-Konishi et al. (20) . The purity of OTA was estimated to be >95% from the area percentage of the chromatogram (data not shown).
Animal treatment
Experiment I: 4-week feeding study of OTA in gpt delta rats. Groups of 10 male gpt delta rats were administered OTA at a concentration of 5 p.p.m. in the basal diet or were fed a basal diet without supplement (control) for 4 weeks. The dietary dose level of 5 p.p.m. was selected as a carcinogenic dose reported in a 2-year carcinogenicity study in rats (21) . Based on a preliminary study of OTA stability, the diet was prepared once every week and was stored in the dark at 4°C prior to use. At necropsy, the kidneys were extirpated, weighed and cut along the long axis. For in vivo reporter gene mutation assays, the ROM was macroscopically separated with curving scissors using the arcuate arteries at the boundary of the cortex and medulla as landmarks, as described in a previous report (6) . The ROMs were stored at −80°C for in vivo mutation assays. Animal treatment of Experiment 1 was performed in our previous study (6) .
Experiment II: 4-week oral gavage study of OTA in gpt delta rats. Groups of five male gpt delta rats were administered OTA by gavage, which is a standard method for in vivo comet assay, at a doses of 70, 210 or 630 µg/10 ml/kg/day for 4 weeks (7 days/week). Animals in the control group were administrated vehicle (0.1 M sodium bicarbonate water) only. OTA solution in 0.1 M sodium bicarbonate water was prepared once every week and was stored in the dark at 4°C prior to use. The doses of 70 and 210 µg/kg/day are carcinogenic doses reported in a 2-year carcinogenicity study in rats (3), and 210 µg/kg/day is equivalent to a dietary dose of 5 p.p.m. Animals were sacrificed 3 hr after the last dosing. The kidneys were extirpated, weighed and cut along the long axis. Half of unilateral kidney was fixed in 10% neutral buffered formalin and routinely processed by embedding in paraffin and sectioning in blocks for immunohistochemical staining. The ROMs were collected as described in our previous study (6) and used for in vivo comet assays, western blotting and quantitative real-time PCR.
In vivo reporter gene mutation assay (Spi − assay) The ROMs from groups of 10 animals in Experiment I were used. Spi − selection was performed using the method of Nohmi et al. (22) . Briefly, genomic DNA was extracted from the ROMs of animals in each group using a Recover Ease DNA isolation kit (Agilent Technologies, Santa Clara, CA, USA), and lambda EG10 DNA (48 kb) was rescued as phages by in vitro packaging using Transpack packaging extract (Agilent Technologies). For Spi − selection, packaged phages were incubated with Escherichia coli XL-1 Blue MRA for survival titration and E.coli XL-1 Blue MRA P2 for mutant selection. Infected cells were mixed with molten lambda-trypticase agar plates. The next day, plaques (Spi − candidates) were punched out with sterilised glass pipettes, and the agar plugs were suspended in SM buffer. The Spi − phenotype was confirmed by spotting the suspensions on three types of plates where XL-1 Blue MRA, XL-1 Blue MRA P2 or WL95 P2 strains were spread in soft agar. Spi − mutants, which made clear plaques on every plate, were counted.
Mutation spectrum analysis of Spi
− mutants Mutation spectrum analysis of Spi − mutants was performed as described in Masumura et al. (23) . Briefly, the lysates of the Spi − mutants were obtained by infection of E.coli LE392 with the recovered Spi − mutants, and the lambda DNA was extracted from the lysates with the Gentra Puregene DNA kit (QIAGEN K.K., Tokyo, Japan). The extracted DNA was used as a template for PCR analysis to determine the deleted regions. DNA fragments containing the deletions were amplified by PCR using primers 001-002 (5 kb in length), 005-012 (14 kb in length) or 005-006 (21 kb in length), followed by sequencing analysis of the PCR products. Sequence changes within and outside of the gam/redBA genes were identified by DNA sequencing analysis at Takara Bio Inc. (Shiga, Japan). The appropriate primers for DNA sequencing were selected based on the results of PCR analysis. The entire sequence of lambda EG10 is available at http://www.nihs.go.jp/dgm/dgm3/gptdeltainfo.html. For the deletion size analysis, we categorised the deletion sizes into single base pair (1 bp), 2 bp-1 kb and >1 kb. Single base pair deletions were subdivided into 'simple' and 'in run'; the former occurred at nonrepetitive sequences, and the latter occurred at repetitive sequences (6) .
The PCR primers used in this study were as follows: primer 001: 5′-CTCTCCTTTGATGCGAATGCCAGC-3′ primer 002: 5′-GGAGTAATTATGCGGAACAGAATCATGC-3′ primer 005: 5′-CGTGGTCTGAGTGTGTTACAGAGG-3′ primer 006: 5′-GTTATGCGTTGTTCCATACAACCTCC-3′ primer 012: 5′-CGGTCGAGGGACCTAATAACTTCG-3′
In vivo comet assay The ROMs from groups of five animals in Experiment II were cut into small pieces in Hanks' balanced salt solution (without Ca 2+ /Mg 2+ ) medium with 1 mM EDTA and 25 mM HEPES containing 10% dimethyl sulfoxide (DMSO) to obtain cell suspensions. Cell suspensions were mixed with 0.5% low-melting point agarose (Takara Bio Inc.) in phosphate-buffered saline and deposited on MAS-coated slide glass (Matsunami Glass Ind. Ltd, Osaka, Japan). The slides were placed in a lysis solution (2.5 mM NaCl, 0.1 M EDTA, 10 mM Tris, 10% DMSO and 1% Triton X-100, pH 10) overnight in a refrigerator. DNA was allowed to denature in electrophoresis buffer (0.3 M NaOH, 1 mM EDTA, pH 13) for 20 min. The slides were placed into a horizontal electrophoresis tank and exposed to 0.7 V/cm (300 mA) for 15 min. The slides were then washed twice in neutralisation buffer (0.4 M Tris, pH 7.5) and dehydrated in ethanol for 5 min. After staining with SYBR Gold (Life Technologies, Carlsbad, CA, USA), at least 100 randomly selected cells per slide were visualised under a fluorescent microscope and subjected to image analysis using Comet Assay IV software (Perceptive Instruments Ltd, Bury St Edmunds, UK). The percentage of DNA in the comet tail (% tail DNA), the tail length and the tail moment were used to evaluate the extent of DNA damage in individual cells.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blotting
The ROMs from groups of four animals in Experiment II were homogenised using a Teflon homogeniser with ice-cold radioimmunoprecipitation assay lysis buffer (Wako Pure Chemical Co., Osaka, Japan) containing mammalian protease inhibitor cocktail and phosphatase inhibitor cocktail 2 and 3 (Sigma-Aldrich, St Louis, MO, USA). Samples were centrifuged at 15 000 × g for 30 min, and the resulting supernatants were used. Protein concentrations were determined using the Advanced Protein Assay (Cytoskeleton, Denver, CO, USA). Samples were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to 0.45-µm polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). For detection of target proteins, membranes were incubated with anti-γ-H2AX monoclonal antibodies, anti-Rad51 monoclonal antibodies (Cell Signaling Technology, Inc., Danvers, MA, USA) or anti-actin monoclonal antibodies (pan Ab-5; Thermo Fisher Scientific, Fremont, CA, USA) at 4°C overnight. Secondary antibody incubation was performed using horseradish peroxidase-conjugated secondary anti-rabbit or mouse antibodies (Cell Signaling Technology) at room temperature. Protein detection was facilitated by chemiluminescence using ECL Prime (GE Healthcare, Little Chalfont, UK), and protein levels were quantified using Image Lab software (Bio-Rad Laboratories, Hercules, CA, USA). Cell extracts for positive control (UV-treated 293 cells) were purchased from Cell Signaling Technology.
Immunohistochemical staining for γ-H2AX
Paraffin-embedded sections from groups of five animals in Experiment II were used. Immunohistochemical staining was performed using monoclonal anti-γ-H2AX antibodies (1:50; Cell Signaling Technology) at 4°C overnight followed by incubation with a high polymer stain at room temperature for 30 min (HISTOFINE Simple Stain; Nichirei Bioscience Inc., Tokyo, Japan).
RNA isolation and quantitative real-time PCR for mRNA expression
The ROMs from groups of five animals in Experiment II were soaked overnight in RNAlater-ICE (Life Technologies) at −20°C, and total RNA was extracted using an RNeasy Mini kit (Qiagen N.V.) according to the manufacturer's instructions. cDNA copies reverse transcribed from total RNA were obtained using a High Capacity cDNA Reverse Transcription kit (Life Technologies). All PCR reactions were performed with primers for rat Chek1, Wee1, Ccna2, Cdk1, Rad51, Rad18, Brip1, Lig4, Xrcc5, Xrcc6, Fen1, Xrcc1, Ercc1 and XPA, and TaqMan Rodent GAPDH Control Reagents were used as an endogenous reference. PCR was carried out in an Applied Biosystems 7900HT FAST RealTime PCR System using TaqMan Fast Universal PCR Master Mix and TaqMan Gene Expression Assays (Life Technologies). The expression levels of target genes were calculated by the relative standard curve method and were determined by normalisation to GAPDH expression. Data were presented as fold change values of treated samples relative to controls.
Statistical analysis
In Experiment I, variance in the data for body and kidney weights, Spi − assays and mutation spectrum analyses of Spi − mutants were checked for homogeneity with the F-test. Student's t-tests were applied for homogeneous data, and Welch's t-tests were applied for heterogeneous data. In Experiment II, variances in the data for body and kidney weights, parameters in comet assays, mRNA levels and protein density data were evaluated for homogeneity using Bartlett's tests. When the data were homogenous, one-way analysis of variance was applied. In heterogeneous cases, the Kruskal-Wallis test was applied. When statistically significant differences were indicated, Dunnett's multiple tests were employed for comparisons between the control and treatment groups.
Results
Experiment I General signs, body weight and kidney weight.
No deaths and no remarkable changes in general signs were observed in any group. In OTA-treated groups, significantly reduced kidney weights were observed (Table I) . Table III . All sizes of deletion mutations, insertions and base substitutions tended to increase following OTA treatment. In particular, the specific mutation frequency of deletions >1 kb increased about 5-fold in the OTA treatment group as compared with the control group (Table  III) . Detail characterisation of deletions >2 bp and complextype deletions identified from OTA-treated and control rats are shown in Figure 1 . 'Complex-type mutants' were defined as deletion mutants whose deletion sizes were not identified or whose junctions were unable to be identified by PCR and sequencing analysis because of complex rearrangements (23) . Sizes of OTA-induced deletion were in the range of 1-5999 bp. Sequences of the junctions of deletions induced by OTA varied and included direct junctions, with microhomology (1-3 bp) or with short insertions (2-3 bp).
Experiment II General signs, body weight and kidney weight. There were no deaths or remarkable changes in general signs in all groups. As compared with the control group, significant decrease in body weights was observed at 630 µg/kg group. Decreases in kidney weights were observed following OTA treatment in a dosedependent manner (Table IV) . In vivo comet assay. DNA damage parameters determined by in vivo comet assay using ROM of the gpt delta rats treated with OTA are summarised in Figure 2 . There were statistically significant increases in tail intensity, tail length and tail moment in all OTA-treated groups.
Western blotting and immunohistochemical staining. Western blotting analysis using anti-γ-H2AX and anti-Rad51 monoclonal antibodies demonstrated increases in the protein expression levels of these targets in the ROMs of gpt delta rats treated with various doses OTA ( Figure 3A ). In addition, there were significant increases in the relative density of protein bands representing γ-H2AX at OTA doses of 210 and 630 µg/kg, using actin as a loading control ( Figure 3B ). Immunohistochemistry analysis revealed punctate signals representing γ-H2AX protein in the nuclei of tubular epithelial cells located in outer stripe of the ROM of gpt delta rats treated with OTA ( Figure 4) . Quantitative real-time PCR. Expression levels of mRNAs encoding cell cycle-related proteins were examined. G 2 /M arrest-related genes, i.e. Chek1 and Wee1, and G 2 /S phaserelated genes, i.e. Ccna2 and Cdk1, were all increased by OTA treatment in a dose-dependent manner ( Figure 5A ). The expression of genes involved in HR repair (Rad51, Rad18 and Brip1) was significantly increased by OTA treatment in a dose-dependent manner ( Figure 5B ). On the other hand, the expression of mRNAs involved in NHEJ repair (Xrcc5, Xrcc6 and Lig4) was not altered by OTA treatment ( Figure 5C ). The expressions of mRNAs involved in base excision repair (Fen1 and Xrcc1) and nucleotide excision repair (Ercc1 and Xpa) were not increased by OTA treatment (Supplementary Figure  S1 , available at Mutagenesis Online).
Discussion
In the present study, 4-week feeding of OTA at a carcinogenic dose increased Spi − MFs in the ROMs of gpt delta rats, in line with our previous report (6) . Mutation spectrum analysis of Spi − mutants (red/gam mutants) demonstrated that OTA caused deletion mutations of various sizes, ranging from 1 to 5999 bp. In particular, the specific mutation frequencies of deletions >1 kb in OTA-treated rats increased 5-fold compared with those in the control group. As reported in in vitro study (24) , these data implied that OTA induced large deletion mutations at the carcinogenic target site.
Exposure of gpt delta mice to IR, UVB and MMC induced large deletions of >1 kb in the red/gam genes at relatively higher level (7). These environmental mutagens are known to induce DNA DSBs possibly due to their characteristic properties, i.e. direct and/or indirect disjuncture of chemical bonds by IR energy, inhibition of DNA replication fork interactions Mean ± SD. *Significantly different from the control group at P < 0.05. **Significantly different from the control group at P < 0.01.
Fig. 2.
Parameters for in vivo comet assay in the ROM of gpt delta rats treated with OTA by oral gavage for 4 weeks. Each value is the mean ± SDs of data for 5 rats. **Significantly different from the control group at P < 0.01. and NHEJ-related genes (Xrcc5, Xrcc6 and Lig4) (C) in the ROM of gpt delta rats treated with OTA for 4 weeks. Each value is the mean ± SDs of data for five rats. Data were normalised to GAPDH mRNA levels. Significantly different from the control group at *P < 0.05 and **P < 0.01.
with UV-induced photoproducts and MMC-induced intrastrand cross-linking (11, 12, 25) . Given that the occurrence of DSBs is thought to be a trigger for large deletion mutations (7, 26, 27) , it is highly probable that OTA has the potential to accumulate DSBs. As DSBs are the most dangerous type of DNA damage affecting maintenance of cellular function, the DNA damage response (DDR), leading to cell cycle arrest and DNA repair, is initiated by DSBs for cellular defence against the accumulation of gene mutations (28, 29) . As one of primary and crucial events of the DDR, ATM-mediated phosphorylation of H2AX (γ-H2AX) occurs, which facilitates the recruitment and retention of a number of DSB repair factors to sites of DSBs (16, 30) . Therefore, the expression of γ-H2AX is thought to be a promising marker of DSBs (31, 32) . In the present study, western blot analysis using protein extracts from ROMs of gpt delta rats revealed obvious increases in γ-H2AX expression by OTA treatment in a dose-dependent manner. In addition, immunohistochemical analysis clearly demonstrated the site-specific localisation of γ-H2AX-positive cells in the tubular epithelium of the outer stripe of the ROM. Comet assays using ROMs of gpt delta rats treated with OTA yielded positive results, suggesting DNA strand breaks, as previously reported (33) (34) (35) (36) . The overall data strongly indicated that OTA induced DSBs in the ROMs of gpt delta rats.
As the detrimental effects of OTA on steric structures of DNA, the formation of OTA-specific DNA adducts were observed in human tissues by 32 P postlabelling methods and were confirmed by mass spectrum analysis in animal tissues (37) (38) (39) (40) . The appearance of apurinic/apyrimidinic (AP) sites in the rat kidney, as well as inhibition of topoisomerase II (TOPOII) activity in cultured cells, have also been reported (41, 42) . It has been accepted that DSBs occur through various causes, such as inhibition of the replication fork due to the formation of bulky adducts, cleavage of AP sites during base excision repair and suppression of TOPOII activity (43) (44) (45) . In particular, AP sites are known to be related with oxidative stress (40) . However, in our previous study, 8-hydroxydeoxyguanosine levels in the kidney DNA of rats treated with OTA were not changed (6) . Treatment with antioxidant affected OTA-induced renal toxicity, but not the carcinogenicity (46) . Thus, the precise mechanisms underlying OTA-induced DSBs remain unclear.
Gene mutations derived from DSBs arise during the repair process, and there are two major pathways mediating DNA repair, NHEJ and HR (17, 18, 47) . These two pathways are mutually exclusive, and the major factor determining which pathway is used is the cell cycle stage (48) . In NHEJ, Xrcc5 and Xrcc6 bind onto broken ends followed by direct ligation by Lig4, and this process occurs throughout the cell cycle (49) . In contrast, HR is initiated by resection of broken ends through interaction with BRCA1, generating single-stranded DNA onto which the Rad51 recombinase assembles as a nucleoprotein filament. Since this structure invades homologous duplex DNA of sister chromatids, which are used as templates for repair DNA synthesis, HR repair is more effective in late S and G 2 phases of cell cycle (50, 51) . OTA induces G 2 /M arrest and increases cell proliferation through another functional mechanism, thereby increasing the ratio of cells in S/G 2 phase (52) (53) (54) . In fact, the present quantitative PCR analysis of mRNA expression also demonstrated that genes related to G 2 /M arrest (Chek1 and Wee1) and S/G 2 phase (Ccna2 and Cdk1) were significantly increased by OTA treatment in a dose-dependent manner. In particular, CDK1 has been reported to accelerate the resection of broken ends in the HR process and simultaneously inhibits NHEJ (46, 47) , implying that DSBs induced by OTA may be repaired predominantly by HR. Additional quantitative PCR analysis has shown that the mRNA expression levels of HR factors [Rad51 and Rad18: recruiters of Rad51 (55) , Brip1: interactor with BRCA1 (56)] increased in response to OTA in a dose-dependent manner, and confirmation of Rad51 overexpression at the protein level strongly supports our hypothesis, despite specific mutation frequencies at the junction sites of Spi − mutants, revealing no obvious characteristics of HR (57) . In contrast, no OTA treatment-related changes were detected in NHEJ factors (Xrcc5, Xrcc6 and Lig4), which were reported to be altered during NHEJ in response to IR (58) . In general, HR is believed to be an error-free repair system. However, there have been several evidences that HR repair can induce large deletion mutations (17, 59 ). Although it is also known that excision of bulky adducts may be a potential source of large deletions (60) , the present data showed that mRNA levels of genes related to base excision and nucleotide excision repair were not increased by OTA treatment. Thus, the overall data suggested that large deletions induced by OTA may occur during HR.
In conclusion, the present data clearly indicated that OTA induced DSBs at carcinogenic target sites in the DNA of gpt delta rats when applied at carcinogenic doses. OTA-induced DSBs appeared to be predominantly repaired by HR, consequently leading to large deletion mutations. Further studies are necessary to clarify the mechanisms underlying OTA-induced DSBs.
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Supplementary Figure S1 is available at Mutagenesis Online.
